Dau‐Ming Niu

4.6k total citations
173 papers, 3.2k citations indexed

About

Dau‐Ming Niu is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Dau‐Ming Niu has authored 173 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Physiology, 54 papers in Molecular Biology and 50 papers in Epidemiology. Recurrent topics in Dau‐Ming Niu's work include Lysosomal Storage Disorders Research (84 papers), Trypanosoma species research and implications (44 papers) and Glycogen Storage Diseases and Myoclonus (35 papers). Dau‐Ming Niu is often cited by papers focused on Lysosomal Storage Disorders Research (84 papers), Trypanosoma species research and implications (44 papers) and Glycogen Storage Diseases and Myoclonus (35 papers). Dau‐Ming Niu collaborates with scholars based in Taiwan, United States and Brazil. Dau‐Ming Niu's co-authors include Hsiang‐Yu Lin, Chih‐Kuang Chuang, Ming‐Ren Chen, Ting‐Rong Hsu, Shuan‐Pei Lin, Wuh‐Liang Hwu, Chuan-Chi Chiang, Chuan‐Hong Kao, Chia‐Feng Yang and Ching‐Yuang Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Dau‐Ming Niu

167 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dau‐Ming Niu Taiwan 31 1.7k 921 802 716 488 173 3.2k
Allan M. Lund Denmark 32 1.1k 0.7× 1.1k 1.2× 674 0.8× 756 1.1× 941 1.9× 171 3.3k
Guillem Pintos‐Morell Spain 25 1.3k 0.8× 490 0.5× 558 0.7× 526 0.7× 449 0.9× 94 2.2k
Paige Kaplan United States 42 2.9k 1.7× 1.6k 1.8× 1.5k 1.9× 647 0.9× 665 1.4× 135 5.7k
J. E. Wraith United Kingdom 37 4.2k 2.5× 573 0.6× 1.9k 2.3× 1.3k 1.9× 204 0.4× 84 5.0k
Marianne Rohrbach Switzerland 26 897 0.5× 631 0.7× 381 0.5× 638 0.9× 116 0.2× 81 2.4k
Nathalie Guffon France 35 5.2k 3.0× 1.2k 1.3× 2.4k 2.9× 1.7k 2.4× 716 1.5× 138 6.5k
C. Ronald Scott United States 26 1.1k 0.6× 966 1.0× 529 0.7× 238 0.3× 121 0.2× 75 2.5k
Joel Charrow United States 46 4.1k 2.4× 1.5k 1.7× 2.8k 3.5× 1.2k 1.7× 338 0.7× 143 7.1k
Marc Nicolino France 31 1.0k 0.6× 1.6k 1.8× 509 0.6× 813 1.1× 155 0.3× 106 4.5k
Stephanie Austin United States 25 776 0.5× 375 0.4× 179 0.2× 1.4k 2.0× 258 0.5× 72 2.0k

Countries citing papers authored by Dau‐Ming Niu

Since Specialization
Citations

This map shows the geographic impact of Dau‐Ming Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dau‐Ming Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dau‐Ming Niu more than expected).

Fields of papers citing papers by Dau‐Ming Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dau‐Ming Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dau‐Ming Niu. The network helps show where Dau‐Ming Niu may publish in the future.

Co-authorship network of co-authors of Dau‐Ming Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Dau‐Ming Niu. A scholar is included among the top collaborators of Dau‐Ming Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dau‐Ming Niu. Dau‐Ming Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramaswami, Uma, Guillem Pintos‐Morell, Christoph Kampmann, et al.. (2025). Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy. Molecular Genetics and Metabolism Reports. 43. 101215–101215. 3 indexed citations
2.
Kuo, Ling, et al.. (2024). Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study. Journal of the American Society of Echocardiography. 37(8). 787–796. 6 indexed citations
3.
Bichet, Daniel G., Robert J. Hopkin, Sridhar R. Allam, et al.. (2023). Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study. Frontiers in Medicine. 10. 1220637–1220637. 10 indexed citations
4.
Cheng, Yen‐Fu, et al.. (2022). Association of Fabry Disease with Hearing Loss, Tinnitus, and Sudden Hearing Loss: A Nationwide Population-Based Study. Journal of Clinical Medicine. 11(24). 7396–7396. 5 indexed citations
5.
Germain, Dominique P., Sergey Moiseev, Fernando Suárez‐Obando, et al.. (2021). The benefits and challenges of family genetic testing in rare genetic diseases—lessons from Fabry disease. Molecular Genetics & Genomic Medicine. 9(5). e1666–e1666. 30 indexed citations
6.
Yang, Chia‐Feng, et al.. (2020). Airway abnormalities in very early treated infantile‐onset Pompe disease: A large‐scale survey by flexible bronchoscopy. American Journal of Medical Genetics Part A. 182(4). 721–729. 10 indexed citations
7.
Lin, Hsiang‐Yu, Chih‐Kuang Chuang, Chung‐Lin Lee, et al.. (2020). Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses. Diagnostics. 10(2). 62–62. 10 indexed citations
8.
Niu, Dau‐Ming, et al.. (2019). Very rare condition of multiple Gaucheroma: A case report and review of the literature. Molecular Genetics and Metabolism Reports. 20. 100473–100473. 15 indexed citations
9.
Lin, Hsiang‐Yu, Chih‐Kuang Chuang, Chung‐Lin Lee, et al.. (2018). Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21‐year period. American Journal of Medical Genetics Part A. 176(9). 1799–1809. 23 indexed citations
10.
Lin, Hsiang‐Yu, Chih‐Kuang Chuang, Chung‐Lieh Hung, et al.. (2016). Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI. Molecular Genetics and Metabolism. 117(4). 431–437. 34 indexed citations
11.
Huang, Chun‐Kai, et al.. (2015). AB067. Glucose tetrasaccharide (Glc4) level in urine sample as a biomarker for Pompe patients.. Annals of Translational Medicine. 3(2). 68–68. 1 indexed citations
12.
Chang, Wei‐Lun, et al.. (2014). A novel mutation of KCNJ11 gene in a patient with permanent neonatal diabetes mellitus. Diabetes Research and Clinical Practice. 104(1). e29–e32. 3 indexed citations
13.
Kaya, Zühre, Dau‐Ming Niu, Aslı Yorulmaz, Aziz Tekin, & Türkiz Gursel. (2014). A novel mutation of ABCG5 gene in a Turkish boy with phytosterolemia presenting with macrotrombocytopenia and stomatocytosis. Pediatric Blood & Cancer. 61(8). 1457–1459. 15 indexed citations
14.
Lin, Hsiang‐Yu, Shou‐Chuan Shih, Chih‐Kuang Chuang, et al.. (2013). Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses. Orphanet Journal of Rare Diseases. 8(1). 71–71. 32 indexed citations
15.
Tsai, Yi‐Giien, Kuender D. Yang, Dau‐Ming Niu, Jien‐Wen Chien, & Ching‐Yuang Lin. (2010). TLR2 Agonists Enhance CD8+Foxp3+ Regulatory T Cells and Suppress Th2 Immune Responses during Allergen Immunotherapy. The Journal of Immunology. 184(12). 7229–7237. 56 indexed citations
16.
Lin, Hsiang‐Yu, Ming‐Ren Chen, Chih‐Kuang Chuang, et al.. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan. Journal of Inherited Metabolic Disease. 33(S3). 421–427. 23 indexed citations
17.
Niu, Dau‐Ming, et al.. (2009). Six New Mutations of the Thyroglobulin Gene Discovered in Taiwanese Children Presenting with Thyroid Dyshormonogenesis. The Journal of Clinical Endocrinology & Metabolism. 94(12). 5045–5052. 30 indexed citations
18.
Lin, Hsiang‐Yu, Chih‐Kuang Chuang, Dau‐Ming Niu, et al.. (2009). Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004. American Journal of Medical Genetics Part A. 149A(5). 960–964. 150 indexed citations
19.
Chiang, Ming‐Chang, Huimei Chen, Yi-Hsin Lee, et al.. (2007). Dysregulation of C/EBPα by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Human Molecular Genetics. 16(5). 483–498. 80 indexed citations
20.
Lin, Shuan‐Pei, et al.. (2006). Clinical Features of Ehlers-Danlos Syndrome. Journal of the Formosan Medical Association. 105(6). 475–480. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026